COVID-19 concerns aggregate around platelets
Open Access
- 10 September 2020
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 136 (11), 1221-1223
- https://doi.org/10.1182/blood.2020007805
Abstract
In this issue of Blood, articles by Manne et al and Hottz et al highlight platelet hyperactivity in COVID-19–associated pathophysiology.1,2 Although the hallmarThis publication has 13 references indexed in Scilit:
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infectionBlood, 2020
- Platelets and ImmunityArteriosclerosis, Thrombosis, and Vascular Biology, 2020
- COVID-19 and its implications for thrombosis and anticoagulationBlood, 2020
- COVID-19: the vasculature unleashedNature Reviews Immunology, 2020
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Thrombocytopenia and its association with mortality in patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Author Correction: A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- The Metabolic Syndrome as a Risk Factor for Venous and Arterial ThrombosisSeminars in Thrombosis and Hemostasis, 2009